735 karma · joined May 29, 2016
It’s a weak line of reasoning to _allow_ cigarettes, but I’m not convinced it’s so bad to _disallow_ novel therapeutic uses that are understudied.
- X-Ray: $15
- Radiologist Consultation: $125
- Harrison.AI interpretation: $20
The cat and mouse between payer and system will never die given how it's set up. There's a disincentive to bill less than maximally, and therefore to not deny and adjust as much as possible. Somewhere in the middle patients get squished with the burden of copays and uncovered expenses that the hospital is now legally obligated to try and collect on or forfeit that portion for all future claims (and still have a copay on that new adjustment)For example, if you ever fly into Bangalore or Mumbai, you'll see GVK on their airports. That's for Gunapati Venkata Krishna Reddy, who goes by GVK. Gunapati is the family name, Venkata Krishna is his given name, and Reddy is the caste name.
Other examples are NT Rama Rao, P.V. Narasimha Rao, and my favorite, is a person I know of who went by KRKVNS Sharma.
For all the comparisons Pichai gets for what he's doing to what Steve Ballmer did at MSFT, at least Ballmer was employee 30 and his war stories were from lived experience. Sundar walked in to a 6 figure job, free food, and the Googleplex and is talking like he was hot-swapping harddrives in the original garage.
I wonder if regulation that stipulated that a change of ownership of some percentage would require recertification of the entity would stem this a bit. Or restrictions on buying HIPAA covered businesses with patient data. Might pose a problem to folks in the business today, but could slow down the massive acquire-and-merge train in these industries.
[0] https://www.reddit.com/r/pics/comments/4xioza/track_cyclists...